Semaglutide (Ozempic · Wegovy)
GLP-1 agonist approved for weight loss and type 2 diabetes
What is Semaglutide
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. It is approved for the treatment of type 2 diabetes (Ozempic) and obesity (Wegovy). It acts by suppressing appetite, delaying gastric emptying, and improving insulin sensitivity.
Sign up free to see more
Create your free account and unlock dozens of complete FDA/EMA-level protocols — dosage, proven benefits and results timeline.
Community reviews
Melhor referência em português que encontrei sobre esse peptídeo. Comprei pelo link do parceiro e chegou certo.
24 de abr. de 2026Funciona, mas exige consistência. As informações de armazenamento e reconstituição foram essenciais pra mim.
18 de abr. de 2026Estou satisfeito até agora. Recomendo ler as contraindicações antes, como o site orienta.
17 de jan. de 2026Efeito mais sutil no meu caso, mas pode ser questão de tempo de uso. O material do site é honesto sobre isso.
11 de jan. de 2026Uso há algumas semanas e os resultados começaram a aparecer. Protocolo bem explicado aqui no site, ajudou muito.
05 de jan. de 2026Leave your review
Where to buy
Semaglutide from Royal Peptides — lab-tested purity and worldwide shipping.
View on Royal PeptidesSome links lead to partners (Royal Peptides). We may earn a commission on purchases at no extra cost to you — this helps keep the platform free.
PeptideMed Plus is an informational platform and affiliate partner. We do not sell, ship or take responsibility for delivery, deadlines, payment, quality, customs or after-sales of the products. The purchase happens entirely on the partner's site, under their and the buyer's sole responsibility.
Quick Facts
This content is informational. Consult a healthcare professional before using any peptide.